University of Virginia team combines focused ultrasound and microRNA to target glioblastoma genes

An experimental strategy using sound waves to deliver microRNA nanoparticles into brain tumours simultaneously silences multiple cancer-driving genes in laboratory models.

Published · AI-drafted summary based on 1 public source
Illustration for generic story
Illustrative image — not from the source article.
Share

Researchers at the University of Virginia have described a multi-component experimental strategy for attacking glioblastoma, the most common and aggressive primary brain tumour in adults. The approach pairs focused ultrasound — which can transiently open the blood-brain barrier — with lipid nanoparticles carrying synthetic microRNA molecules designed to suppress several pro-tumourigenic genes at once.

MicroRNAs are short non-coding RNA sequences that regulate gene expression post-transcriptionally. In cancer, certain microRNAs act as tumour suppressors, and their loss or downregulation has been documented in glioblastoma. Delivering therapeutic microRNAs into brain tissue is technically challenging because the blood-brain barrier restricts the passage of large or charged molecules; focused ultrasound in combination with microbubbles is an established research technique for transient, localised barrier opening.

The Virginia team's strategy targets multiple cancer-driving genes simultaneously, an approach intended to reduce the likelihood of resistance that can arise when single-target therapies are used. The research is at a preclinical stage; the specific microRNA sequences, target genes, animal model data, and journal of publication were not available from the feed summary alone. This is an educational summary based on public reporting; the findings do not represent a clinical treatment option at this time.

Sources

Read the original reporting — these are the public sources this summary draws from.

  1. Primary source ScienceDaily · 2026-11-01
    Scientists use sound waves to deliver a new attack on deadly brain cancer

Tags

glioblastoma microrna focused-ultrasound nanoparticles blood-brain-barrier rna-therapeutics brain-cancer cancer-biology
Share

About Genetic Current

Educational summaries of public genetics news

Genetic Current is the news section of Evagene, an academic, research, and educational pedigree-modelling platform. Stories are AI-drafted summaries of items from trusted public sources, written for researchers, clinicians, educators, students, genealogists, and patients with an interest in genetics. Summaries are for educational and research purposes only and are not medical advice.

Join the Evagene Alpha Waiting List